← back to search

Yuling Chen

North Sichuan Medical University · CN
Area of research
Oncology · Cancer Research
Research interest
Research interests include Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics, and Immune cells in cancer.
h-index
24
citations
1,851
works
133
NIH funding
primary concept
email

Recent publications

Neoadjuvant treatment of IBI310 (anti-CTLA-4 antibody) plus sintilimab (anti-PD-1 antibody) in patients with microsatellite instability-high/mismatch repair-deficient colorectal cancer: Results from a randomized, open-labeled, phase Ib study.
Journal of Clinical Oncology 2024cited by 18position: middledoi
Mass Production of Sulfur‐Tuned Single‐Atom Catalysts for Zn–Air Batteries
Advanced Materials 2023cited by 104position: middledoi
Enhanced pericyte-endothelial interactions through NO-boosted extracellular vesicles drive revascularization in a mouse model of ischemic injury
Nature Communications 2023cited by 27position: middledoi
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
Nature Communications 2023cited by 23position: middledoi
Abstract CT078: First-line treatment with sintilimab (sin) vs placebo in combination with chemotherapy (chemo) in patients (pts) with unresectable gastric or gastroesophageal junction (G/GEJ) cancer: Final overall survival (OS) results from the randomized, phase III ORIENT-16 trial
Cancer Research 2023cited by 14position: middledoi
The dose-related plateau effect of surviving fraction in normal tissue during the ultra-high-dose-rate radiotherapy
Physics in Medicine and Biology 2023cited by 6position: middledoi
Nerve function restoration following targeted muscle reinnervation after varying delayed periods
Neural Regeneration Research 2023cited by 6position: middledoi
Genomic insights and prognostic significance of novel biomarkers in pancreatic ductal adenocarcinoma: A comprehensive analysis
Biochemistry and Biophysics Reports 2023cited by 5position: firstdoi
A study to evaluate the safety, tolerability, and efficacy of IBI939 in combination with sintilimab in patients with previously untreated locally advanced unresectable or metastatic PD-L1–selected non–small-cell lung cancer (NSCLC): Updated efficacy and safety results.
Journal of Clinical Oncology 2023cited by 2position: middledoi
LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration
Technology in Cancer Research & Treatment 2022cited by 70position: lastdoi
Unsaturated Fatty Acid Liposomes Selectively Regulate Glutathione Peroxidase 4 to Exacerbate Lipid Peroxidation as an Adaptable Liposome Platform for Anti-Tumor Therapy
Molecular Pharmaceutics 2022cited by 25position: middledoi
Age-related increase of mitochondrial content in human memory CD4+ T cells contributes to ROS-mediated increased expression of proinflammatory cytokines
Frontiers in Immunology 2022cited by 19position: firstdoi
Inhibition of Complex I of the Respiratory Chain, but Not Complex III, Attenuates Degranulation and Cytokine Secretion in Human Skin Mast Cells
International Journal of Molecular Sciences 2022cited by 8position: middledoi
Hypoxia/HIF Modulates Immune Responses
Biomedicines 2021cited by 103position: firstdoi
PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma
Oncology Letters 2021cited by 11position: middledoi
Production of IL-6 and Phagocytosis Are the Most Resilient Immune Functions in Metabolically Compromised Human Monocytes
Frontiers in Immunology 2021cited by 10position: middledoi
Metabolism of T Lymphocytes in Health and Disease
International review of cell and molecular biology 2018cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yuanchun Ye · The Seventh Affiliated Hospital of Sun Yat-sen University5 papers (2021–2023)Timo Gaber · Leibniz Association5 papers (2018–2022)Pierre-Louis Krauß · Humboldt-Universität zu Berlin4 papers (2018–2022)Frank Buttgereit · Humboldt-Universität zu Berlin4 papers (2018–2022)Thomas Buttgereit · Humboldt-Universität zu Berlin3 papers (2021–2022)Moritz Pfeiffenberger · Humboldt-Universität zu Berlin3 papers (2021–2022)Ouyang Ge · Humboldt-Universität zu Berlin2 papers (2021–2022)Yuanjie Bi · Sun Yat-sen University2 papers (2023–2023)Alexandra Damerau · Leibniz Association2 papers (2021–2022) · 2 papers (2021–2023)Min Feng · Shanghai Normal University2 papers (2022–2023)Jianming Xu · University of Technology Sydney1 papers (2023–2023)Haipeng Zhang · Tongji University1 papers (2023–2023)Kangsheng Gu · Jiangnan University1 papers (2023–2023)Fang Wang · Nanchang University1 papers (2023–2023)Ying Li · Hebei Medical University1 papers (2023–2023)Peng Cui · Medical College of Wisconsin1 papers (2023–2023)Xi Lin · South China Agricultural University1 papers (2023–2023) · 1 papers (2024–2024)Guo‐Cai Wang · Guangzhou University of Chinese Medicine1 papers (2023–2023)